MedPath

A clinical trial to study the effect of periodontal treatment on rheumatoid arthritis disease

Not Applicable
Completed
Conditions
Health Condition 1: null- Rheumatoid Arthritis patients with chronic periodontitis
Registration Number
CTRI/2017/01/007713
Lead Sponsor
Divvi Anusha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.Subjects willing to give written informed consent

2.Patients with rheumatoid arthritis (RA) diagnosed according to the revised 2010 ACR criteria and with joint involvement score of 3 (4-10 small joints with or without involvement of large joints) for the classification of RA

3.Patients with moderate chronic periodontitis (at least 2 interproximal sites not on the same tooth with probing depth of >=5 to <7 mm or clinical attachment loss 3 to 4 mm) with at least 20 teeth present

4. Patients under similar medication for rheumatoid arthritis.

Exclusion Criteria

1.Mild and Severe chronic periodontitis

2.Antibiotic therapy and periodontal therapy in last 3 months

3.History of systemic diseases

4.History of hypersensitivity to mouthwash

5.Using any mouthwash/rinse in the last month

6.Smoking

7. Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in probing depth and clinical attachment loss and reduction in the levels of anti-citrullinated protein antibody (ACPA), Rheumatoid factor, C-reactive protein and erythrocyte sedimentation rate (ESR)Timepoint: 6 weeks
Secondary Outcome Measures
NameTimeMethod
Reduction in the levels of anti-citrullinated protein antibody (ACPA), Rheumatoid factor, C-reactive protein and erythrocyte sedimentation rate (ESR)Timepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath